CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
|Articles|December 1, 2001
Technology purchases must be effective, not just efficient
How much should a managed care organization invest in information technology?How can an MCO ensure that IT is making a worthwhile contribution to itsbusiness? The answers to these questions will be central to business successin the 21st century as MCOs must balance effectiveness (getting the businessdone well) with efficiency (getting it done at minimal cost). Current ITbenchmarks and measurement systems are failing to demonstrate business value.
Advertisement
Advertisement
Related to this article
Dunn of NeosRx says a 340B shift from discounts to rebates likely won't affect rebate erosion affecting plan sponsors.
Five transcranial magnetic stimulation sessions in one day improved processing speed in adults with schizophrenia, which holds promise for future treatment possibilities, according to researcher Heather Burrell Ward, M.D.
Imaging has been associated with four of the five most prevalent low-value services among Medicare beneficiaries.
One of teledentistry's most valuable applications is triage — helping a patient understand whether a concern can wait for an appointment, requires prompt attention or warrants emergency medical care.
Low birth volume fuels rural healthcare obstetric closures, limiting women’s health access—see which hospitals are most at risk.
In both mice and human cells, a small molecule selectively blocked the activity of MAP4K4, a protein involved in several major biological pathways.
Steering claims away from 340B-eligible pharmacies is one option but also the most disruptive, said Jeff Dunn, Pharm.D., MBA, of NeosRx.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Texas A&M researchers discover promising therapy for fatty liver disease
2
Jeff Dunn, Pharm.D., MBA, on 340B rebates vs. discounts — and transparency | PBMI 2026
3
The hidden costs of routine radiology and how they can be addressed
4
FDA approves Lilly’s Onswik, the second once-weekly insulin
5